Biotechnology Bulletin ›› 2013, Vol. 0 ›› Issue (3): 139-143.

• Research report • Previous Articles     Next Articles

The Production and Application of TRIP-1 Antibody

Zhang Honglin,g Wan Jun, Dong Yichen, Cao Wei, Zhang Xinsheng, Zhang Jinxie, Huang Laiqiang   

  1. 1. School of Life Sciences,Tsinghua University,Beijing 100084;2. The Shenzhen Key Lab of Gene and Antibody Therapy,Center for Biotech & Biomedicine and Division of Life & Health Sciences,Graduate School at Shenzhen,Tsinghua University,Shenzhen 518055)
  • Received:2012-08-24 Revised:2013-03-21 Online:2013-03-20 Published:2013-03-21

Abstract: To produce antibody against the TGF-β type II receptor binding protein, TRIP-1, contributing to study TRIP-1’s function in TGF-β signaling pathway and cancer development. Human’s TRIP-1 gene was cloned into the prokaryotic expression vector of pET-His, and then transformed into E. coli BL21 to induce TRIP-1 protein expression. Purified TRIP-1 protein was used to immunize New Zealand rabbits and Kunming mice(KM). The serum was removed and the titer and affinity was determined after immunization 4 times. The antiserum was highly purified by proteinG. Results indicated that the titer of the anti-serum from murine and rabbit are high enough for Western blot and immunofluorescence assay.

Key words: Prokaryotic expression and purification TRIP-1, Animal immunization, Anti-serum, Antibody identification